share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schneider Jennifer

SEC ·  May 18 04:25
Summary by Futu AI
Jennifer Schneider, associated with Vertex Pharmaceuticals Inc. [VRTX], was granted 922 shares of common stock on May 15, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Schneider directly holds a total of 922 shares in the company. The grant represents an increase in Schneider's stake in Vertex Pharmaceuticals, potentially aligning her interests more closely with those of shareholders.
Jennifer Schneider, associated with Vertex Pharmaceuticals Inc. [VRTX], was granted 922 shares of common stock on May 15, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Schneider directly holds a total of 922 shares in the company. The grant represents an increase in Schneider's stake in Vertex Pharmaceuticals, potentially aligning her interests more closely with those of shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.